What category of drugs includes phenothiazines and butyrophenones, used for psychosis?

The category that includes phenothiazines and butyrophenones, which are used for treating psychosis, is short-acting antipsychotics. Phenothiazines, such as chlorpromazine, and butyrophenones, like haloperidol, are often classified under this umbrella because they provide rapid control of acute symptoms associated with psychotic disorders, including schizophrenia.

Short-acting antipsychotics are known for their immediate effects in managing acute episodes of psychosis, making them essential in crisis situations. Their fast onset of action allows clinicians to stabilize patients quickly, which is critical in acute care settings.

This classification is distinct from long-acting antipsychotics, which are generally intended for maintenance treatment and prevention of relapse, rather than immediate symptom control. Antidepressants and mixed medications do not primarily focus on the treatment of psychosis, and thus are not included in this category. Understanding the roles of these medications helps in the effective management of psychotic disorders, ensuring patients receive the timely care they need.